当前位置: 首页 > 详情页

Rapamycin Promotes the Autophagic Degradation of Oxidized Low-Density Lipoprotein in Human Umbilical Vein Endothelial Cells

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [a]Department of Neurology, Second Affiliated Hospital of Soochow University, Suzhou , China [b]Institute of Neuroscience, Soochow University, Suzhou , China [c]Department of Neurology, Suzhou Hospital of Traditional Chinese Medicine, Suzhou , China
出处:
ISSN:

关键词: Rapamycin Oxidized low-density lipoprotein Human umbilical vein endothelial cells Degradation Autophagy/lysosome pathway

摘要:
Background/Aims: Oxidized low-density lipoprotein (oxLDL) has been extensively implicated in the initiation of atherosclerosis. Our previous studies reported that ox-LDL could activate autophagy in human umbilical vein endothelial cells (HUVECs). Because of this, subsequent studies were designed to elucidate the possible role of the autophagic inducer, rapamycin, on ox-LDL degradation in endothelial cells. Methods: Intracellular cholesterol content was measured using a tissue total cholesterol assay kit. ox-LDL trafficking within endothelial cells was analyzed by flow cytometry. Levels of proteins involved in the autophagic process, microtubule-associated protein 1 light chain 3 (MAP1-LC3), lysosome-associated membrane protein 1 (LAMP1), Beclin 1 and p62, were assessed by Western blot analysis. Results: We discovered that rapamycin could decrease the ox-LDL content in HUVECs at the 3-hour time point. Rapamycin also mediated an obvious increase in Dil-labeled ox-LDL (Dil-oxLDL)/LC3 and Dil-ox-LDL/LAMP1 co-localization, which was inhibited by 3-methyladenine (3-MA), an autophagic inhibitor. In addition, significant co-localization of LC3 and LAMP1 occurred in cells pretreated with rapamycin. In the presence of rapamycin, p62 levels were reduced, and autophagic flux was enhanced. Conclusion: These data demonstrate that the activation of the autophagy-lysosome pathway by rapamycin may accelerate ox-LDL degradation.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2014]版:
大类 | 3 区 医学
小类 | 3 区 生理学 4 区 外周血管病
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 外周血管病 4 区 生理学
JCR分区:
出版当年[2013]版:
Q2 PHYSIOLOGY Q2 PERIPHERAL VASCULAR DISEASE
最新[2023]版:
Q3 PERIPHERAL VASCULAR DISEASE Q3 PHYSIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2013版] 出版当年五年平均 出版前一年[2012版] 出版后一年[2014版]

第一作者:
第一作者机构: [a]Department of Neurology, Second Affiliated Hospital of Soochow University, Suzhou , China
通讯作者:
通讯机构: [*1]Department of Neurology,Second Affiliated Hospital of Soochow University ,1055 Sanxiang Road, Suzhou 215004
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院